Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Foot pressure feedback boosts robot walking training in stroke patients

NCT ID NCT07336667

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study tested whether adding foot pressure feedback to robot-assisted walking training helps improve walking symmetry and balance in people who have had a stroke and have weakness on one side. Sixteen adults with chronic hemiplegia completed a 4-week program using a Lokomat robot, with or without extra foot pressure feedback. The goal was to see if the feedback group had better gains in walking and balance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

16 people

The number who actually took part.

Started

Feb 2026

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients with hemiplegia after stroke who are currently admitted to or visiting the rehabilitation therapy department of Seoul Brain Hospital in Yeongdeungpo-gu, Seoul, Republic of Korea. * Chronic stage after stroke onset of at least 6 months. * Diagnosis of unilateral hemiplegia. * Mini-Mental State Examination(MMSE) score ≥ 24, with ability to understand the study procedures and provide informed consent. * Functional Ambulation Catefories(FAC) score of 1-2(FAC 0 excluded.) * Ability to communicate voluntarily for participation and consent. * Suiable physical condition for robot-assisted gait training(RAGT) and use of Lokomat device, including body weight ≤ 135 kg and height between approximately 150 cm and 2.0 m. Exclusion Criteria: * MMSE score ≤ 23, indicating difficulty understanding the study procedures or expressing informed consent. * History of major psychiatric disorders such as schizophrenia, major depressive disorder, or bipolar disorder. * Uncontrolled cardiovascular or respiratory disease that makes gait training unsafe, such as uncontrolled hypertension, significant arrhythmia, angina, or acute exacerbation of respiratory disease. * Orthopedic or neuromuscular conditions that prevent safe robotic gait training, including: * Lower limb surgery or fracture within the previous 3 months. * Moderate-to-severe joint contracture or severe spasticity (e.g., Modified Ashworth Scale ≥ 3). * Clinically significant leg-length discrepancy (≥ 2 cm). * Severe skin infection, pressure ulcer, or other skin condition at the harness or strap contact areas that makes physical contact difficult. * Low back pain, dizziness, orthostatic hypotension, or other symptoms that prevent continuation of RAGT. * Acute or recurrent neurological events within the previous 3 months (e.g., recurrent cerebrovascular events). * Any other medical condition that the principal investigator judges to make participation unsafe. Vulnerable Populations: This study includes only adult participants and does not enroll legally vulnerable populations such as minors or pregnant women. For inpatients, potential reduction in voluntariness due to relationships with treating clinicians is minimized by obtaining consent from a non-treating researcher, allowing sufficient time for decision-making, permitting withdrawal at any time without penalty, and allowing a caregiver to be present during the consent process if desired.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiplegia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Duksoo Medical Foundation Seoul Brain Hospital

    Seoul, Seoul, 07301, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.